Patent · US Active

Dermatological compositions comprising avermectin nanocapsules

US8491928B2 · kind B2 · utility

2Cited by

3References

20Claims

0Family size

Assignee

Galderma Holding SA · CH

Inventors

Claire Mallard · Mougins, FR
Lara Baudonnet · Fonsorbes, FR

Key dates

Filing date	Oct 9, 2012
Grant date	Jul 23, 2013
Priority date	—
Expiry date	Oct 9, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S977/907
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions and nanoemulsions containing lipid nanocapsules dispersed in a hydrophilic phase, such nanocapsules including at least one avermectin compound, are useful for the treatment of dermatological pathologies, e.g., rosacea.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.